IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cell and enhances IGF-1-induced mitogenesis

Journal of Virology

Volumn 78, Issue 11, 2004, Pages 5720-5727

  Baege, Astrid C ^a   Disbrow, Gary L ^a   Schlegel, Richard ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIVISION; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16 E6; HUMAN PAPILLOMAVIRUS TYPE 16 E7; IMMUNOBLOTTING; MITOGENESIS; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETROVIRUS; SENESCENCE; SIGNAL TRANSDUCTION; UTERINE CERVIX; WART VIRUS;

CELL AGING; CELL DIVISION; CELLS, CULTURED; CERVIX UTERI; DNA; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ONCOGENE PROTEINS, VIRAL; RECEPTOR, IGF TYPE 1; REPRESSOR PROTEINS;

EID: 2442697703     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.11.5720-5727.2004     Document Type: Article

References (51)

1. Andreatta-Van Leyen, S., J. R. Hembree, and R. L. Eckert. 1994. Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. J. Cell. Physiol. 160:265-274.
2. Baege, A. C., A. Berger, R. Schlegel, T. Veldman, and R. Schlegel. 2002. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am. J. Pathol. 160:1251-1257.
3. Barreca, A., M. De Luca, P. Del Monte, S. Bondanza, G. Damonte, G. Cariola, E. Di Marco, G. Giordano, R. Cancedda, and F. Minuto. 1992. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J. Cell. Physiol. 151:262-268.
4. Baserga, R. 1995. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res. 55:249-252.
5. Baserga, R., A. Hongo, M. Rubin, M. Prisco, and B. Valentinis. 1997. The IGF-1 receptor in cell growth, transformation and apoptosis. Biochem. Biophys. Acta 1332:105-126.
6. Baxter, R. C., and J. L. Martin. 1989. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog. Growth Factor Res. 1:49-68.
7. Baxter, R. C. 2000. Insulin-like growth factor (IGF)-binding proteins: interactions with IGF's and intrinsic bioactivities. Am. J. Physiol. Endocrinol. Metab. 278:967-976.
8. Baxter, R. C. 2001. Signaling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol. Pathol. 54:145-148.
9. Berger, A. J., A. Baege, T. Guillemette, J. Deeds, R. Meyer, G. Disbrow, R. Schlegel, and R. Schlegel. 2002. Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am. J. Pathol. 161:603-610.
10. Chen, J.-C., Z. M. Shao, M. S. Sheikh, A. Hussain, D. LeRoith, C. T. Roberts, and J. A. Fontana. 1994. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-1 (IGF-1)-mediated DNA synthesis and IGF-1 binding in a human breast carcinoma cell line. J. Cell. Physiol. 158:69-78.
11. Clemmons, D. R. 1997. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 8:45-62.
12. Conover, C. A., M. Ronk, F. Lombana, and D. R. Powell. 1990. Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology 127:2795-2803.
13. Conover, C. A., and D. R. Powell. 1991. Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-1 induced receptor down regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 129:710-716.
14. Conover, C. A. 1992. Potentiation of insulin like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130:3191-3199.
15. Conover, C. A., J. T. Clarkson, and L. K. Bale. 1995. Effects of glucocorticoids on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology 136:1403-1410.
16. Conover, C. A., J. T. Clarkson, and L. K. Bale. 1996. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. Endocrinology 137:2286-2292.
17. DeMellow, J. S. M., and R. C. Baxter. 1988. Growth hormone-dependent insulin like growth factor (IGF) binding protein both inhibits and potentiates IGF-1 stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 156:199-204.
18. D'Ercole, A. J., and A. S. Calikoglu. 2001. The case of local versus endocrine IGF-1 actions: the jury is still out. Growth Hormone IGF Res. 11:261-265.
19. Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
20. Ernst, M., and G. A. Rodan. 1990. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:8070-8814.
21. Firth, S. M., U. Ganeshprasad, and R. C. Baxter. 1998. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J. Biol. Chem. 273:2631-2638.
22. Giovannucci, E. 1999. Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Hormone Res. 3:34-41.
23. Goldstein, S., E. J. Moerman, R. A. Jones, and R. C. Baxter. 1991. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc. Natl. Acad. Sci. USA 88:9680-9684.
24. Grill, C. J., and W. S. Cohick. 2000. Insulin-like growth factor binding protein-3 mediates IGF-1 action in a bovine mammary epithelial cell line independent of an IGF interaction. J. Cell. Physiol. 183:273-283.
25. Grimberg, A., and P. Cohen. 2000. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell. Physiol. 183:1-9.
26. Hankinson, S. E., W. C. Willett, G. A. Colditz, D. J. Hunter, D. S. Michaud, B. Deroo, B. Rosner, F. E. Speizer, and M. Pollak. 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351:1393-1396.
27. Hembree, J. R., C. Agarwal, and R. L. Eckert. 1994. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16 immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1. Cancer Res. 54:3160-3166.
28. Hochscheid, R., G. Jaques, and B. Wegmann. 2000. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. J. Endocrinol. 166:553-563.
29. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 and 18. EMBO J. 10:4129-4135.
30. Huynh, H., V. F. Yang, and M. Pollak. 1996. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein-3 autocrine loop in human breast cancer cells. J. Biol. Chem. 271:1016-1021.
31. Ikonen, M., B. Liu, Y. Hashimoto, L. Ma, K.-W. Lee, T. Niikura, I. Nishimoto, and P. Cohen. 2003. Interaction between Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein-3 regulates cell survival and apoptosis. Proc. Natl. Acad. Sci. USA 100:13042-13047.
32. Karas, M., M. Danilenko, D. Fishman, D. LeRoith, J. Levy, and Y. Sharoni. 1997. Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-1-induced insulin-like growth factor-1 receptor signaling in Ishikawa endometrial cancer cells. J. Biol. Chem. 26:16514-16520.
33. Katz, L. E. L., R. G. Rosenfeld, and P. Cohen. 1995. Clinical significance of insulin-like growth factor binding proteins (IGFBP's). Endocrinologist 5:36-43.
34. Kelley, K. M., Y. Oh, S. E. Gargosky, Z. Gucev, T. Matsumoto, V. Hwa, L. Ng, D. M. Simpson, and R. G. Rosenfeld. 1996. Insulin-like growth factor binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 28:619-637.
35. Khosravi, J., A. Diamandi, J. Mistry, and A. Scorilas. 2001. Insulin-like growth factor I (IGF-1) and IGF-binding protein-3 in benign prostatic hyperplasia and prostatic cancer. J. Clin. Endocrinol. Metab. 86:694-699.
36. Liu, B., H. Y. Lee, S. A. Weinzimer, D. R. Powell, J. L. Clifford, J. M. Kurie, and P. Cohe. 2000. Direct functional interactions between insulin-like growth factor binding protein-3 and retinoid-X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 275:33607-33613.
37. Mohensi-Zadeh, S., and M. Binoux. 1997. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 38:5645-5648.
38. Münger, K., B. A. Werness, N. Dyson, W. C. Phlebs, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
39. Nees, M., J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. Woodworth. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappa-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.
40. Oh, Y., H. L. Muller, H. Pham, and R. G. Rosenfeld. 1993. Demonstration of receptors of insulin-like growth factor binding protein-3 on HS578T breast cancer cells. J. Biol. Chem. 268:26045-26048.
41. Ohlsson, C., K. Sjögren, J.-O. Jansson, and O. G. P. Isaksson. 2000. The relative importance of endocrine versus autocrine/paracrine insulin-like growth factor-1 in the regulation of body growth. Pediatr. Nephrol. 14:541-543.
42. Probst-Hensch, N. M., J.-M. Yuan, F. Z. Stanczyk, Y.-T. Gao, R. K. Ross, and M. C. Yu. 2001. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br. J. Cancer 85:1695-1699.
43. Radulescu, R. T. 1994. Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem. Sci. 19:278.
44. Schedlich, L. J., T. F. Young, S. M. Firth, and R. C. Baxter. 1998. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273:18347-18352.
45. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
46. Schwarze, R. S., S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. F. Jarrard. 2002. Novel pathways associated with bypassing cellular senescence in human epithelial cells. J. Biol. Chem. 277:14877-14883.
47. Vadgama, J. V., Y. Wu, G. Datta, H. Khan, and R. Chillar. 1999. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 57:330-340.
48. Yu, H., M. R. Spitz, J. Mistry, J. Gu, G. K. Hong, and X. Wu. 1999. Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91:151-156.
49. Zheng, B., and D. R. Ciemmons. 1998. Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 95:11217-11222.
50. zur Hausen, H. 1996. Papillomavirus infections-a major cause of human cancers. Biochem. Biophys. Acta 1288:55-78.
51. zur Hausen, H. 2000. Papillomavirus causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-798.